https://orcid.org/0000-0002-2213-9631
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pramod G. Nagaraju, Ashwini S & Poornima Priyadarshini. (2023) Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease. Critical Reviews in Food Science and Nutrition 63:32, pages 11153-11168.
Read now
Read now
Hongqian Lv, Yan Wang, Xiaotong Yang, Guixia Ling & Peng Zhang. (2023) Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment. Nutritional Neuroscience 26:8, pages 727-742.
Read now
Read now
Jiao Wang, Liang Kong, Rui-Bo Guo, Si-Yu He, Xin-Ze Liu, Lu Zhang, Yang Liu, Yang Yu, Xue-Tao Li & Lan Cheng. (2022) Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease. Drug Delivery 29:1, pages 1648-1662.
Read now
Read now
Sopan Nangare & Pravin Patil. (2022) Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer’s Disease: Development and Future Prospects. Critical Reviews in Analytical Chemistry 52:5, pages 1139-1169.
Read now
Read now
Articles from other publishers (16)
Sweta Priyadarshini Pradhan, Pratap Kumar Sahu & Anindita Behera. (2023) New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease. Molecular and Cellular Biochemistry 478:12, pages 2739-2762.
Crossref
Crossref
Sankha Bhattacharya. (2023) Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of
Dementia Patients. Current Pharmaceutical Biotechnology 24:9, pages 1108-1121.
Crossref
Crossref
Laura Marinela Ailioaie, Constantin Ailioaie & Gerhard Litscher. (2023) Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?. Pharmaceutics 15:3, pages 916.
Crossref
Crossref
Nadiyeh Rouhi, Abbas Akhgari, Neda Orouji, Alireza Nezami, Milad Rahimzadegan & Hossein Kamali. (2023) Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers. Journal of Pharmaceutical and Biomedical Analysis 222, pages 115084.
Crossref
Crossref
Taís C. Ribeiro, Rafael M. Sábio, Gabriela C. Carvalho, Bruno Fonseca-Santos & Marlus Chorilli. (2022) Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment. International Journal of Pharmaceutics 624, pages 121978.
Crossref
Crossref
Mohammad Saeedi & Fatemeh Mehranfar. (2022) Challenges and Approaches of Drugs Such as Memantine,
Donepezil, Rivastigmine, and Aducanumab in the Treatment,
Control and Management of Alzheimer's Disease. Recent Patents on Biotechnology 16:2, pages 102-121.
Crossref
Crossref
Małgorzata Milewska, Andrzej Milewski, Ilona Wandzik & Martina H. Stenzel. (2022) Structurally analogous trehalose and sucrose glycopolymers – comparative characterization and evaluation of their effects on insulin fibrillation. Polymer Chemistry 13:13, pages 1831-1843.
Crossref
Crossref
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim & Rudolph E. Tanzi. (2022) Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease. Frontiers in Neuroscience 16.
Crossref
Crossref
T.S. Sindhu, N. Kumaratharan & P. Anandan. (2022) Review on Automatic Detection of Alzheimer Disease. Review on Automatic Detection of Alzheimer Disease.
Navjot Kaur, Vanktesh Kumar, Thatikayala Mahender, Indrani Maji, Srushti Mahajan, Mayur Aalhate, Pankaj Kumar Singh & Sanjeev Kumar Sahu. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
67
79
.
Francisca Espinoza, Walther Ide, Natalia Saldivia & Diego Zelada. 2022. Polymeric Biomaterials for Healthcare Applications. Polymeric Biomaterials for Healthcare Applications
369
402
.
Ramazan Ceylan, Ayse Demirbas, Ismail Ocsoy & Abdurrahman Aktumsek. (2021) Green synthesis of silver nanoparticles using aqueous extracts of three Sideritis species from Turkey and evaluations bioactivity potentials. Sustainable Chemistry and Pharmacy 21, pages 100426.
Crossref
Crossref
Muhammad Bilal, Mahmood Barani, Fakhara Sabir, Abbas Rahdar & George Z. Kyzas. (2020) Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview. NanoImpact 20, pages 100251.
Crossref
Crossref
Ha Thi Thu Do & Jungsook Cho. (2020) Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer’s Disease, Parkinson’s Disease, and Depression with Pharmacokinetic and Safety Profiles. International Journal of Molecular Sciences 21:17, pages 6211.
Crossref
Crossref
Yanyue Wu, Zhiguo Lu, Yan Li, Jun Yang & Xin Zhang. (2020) Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection. Nanomaterials 10:8, pages 1441.
Crossref
Crossref
. (2020) Possible Link between Porphyromonas gingivalis and Amyloidosis in the Pathogenesis of Alzheimer’s and Parkinson’s Disease.. International Journal of Pathology and Immunology, pages 1-12.
Crossref
Crossref